X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61372) 61372
Newspaper Article (11312) 11312
Book Chapter (673) 673
Newsletter (588) 588
Book / eBook (291) 291
Conference Proceeding (193) 193
Dissertation (183) 183
Magazine Article (102) 102
Reference (56) 56
Publication (51) 51
Government Document (31) 31
Journal / eJournal (29) 29
Trade Publication Article (23) 23
Web Resource (16) 16
Book Review (7) 7
Report (5) 5
Paper (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
polypeptides (32131) 32131
animals (23039) 23039
humans (19438) 19438
proteins (13940) 13940
biochemistry & molecular biology (11749) 11749
male (11539) 11539
female (8379) 8379
polypeptide (8017) 8017
rats (7762) 7762
amino acid sequence (6706) 6706
molecular sequence data (6461) 6461
peptides (6186) 6186
inventors (5980) 5980
mice (5582) 5582
research (5348) 5348
amino acids (5343) 5343
endocrinology & metabolism (5051) 5051
analysis (4695) 4695
expression (4580) 4580
vasoactive intestinal polypeptide (4481) 4481
neurosciences (4330) 4330
adult (4270) 4270
cell biology (4208) 4208
pharmacology & pharmacy (4118) 4118
enzymes (3518) 3518
middle aged (3482) 3482
protein (3394) 3394
gene expression (3308) 3308
physiology (3175) 3175
biophysics (3166) 3166
physiological aspects (3056) 3056
immunohistochemistry (2970) 2970
insulin (2946) 2946
multidisciplinary sciences (2891) 2891
identification (2695) 2695
kinetics (2665) 2665
cells (2641) 2641
islet amyloid polypeptide (2609) 2609
base sequence (2560) 2560
research article (2441) 2441
peptides - chemistry (2438) 2438
chemistry, multidisciplinary (2409) 2409
models, molecular (2362) 2362
protein conformation (2288) 2288
aged (2281) 2281
peptide (2280) 2280
pituitary adenylate cyclase-activating polypeptide (2255) 2255
diabetes (2254) 2254
glucose (2253) 2253
protein binding (2197) 2197
life sciences (2177) 2177
genes (2147) 2147
biochemistry (2133) 2133
secretion (2133) 2133
mutation (2124) 2124
cancer (2119) 2119
protein folding (2097) 2097
cyclase-activating polypeptide (2074) 2074
cells, cultured (2048) 2048
binding (2026) 2026
rat (2025) 2025
biology (1992) 1992
binding sites (1948) 1948
antigens (1920) 1920
cell line (1915) 1915
methods (1907) 1907
glucagon-like peptide-1 (1898) 1898
rats, sprague-dawley (1875) 1875
medicine (1837) 1837
chemistry, physical (1822) 1822
molecular weight (1781) 1781
rodents (1773) 1773
insulin - metabolism (1768) 1768
immunology (1743) 1743
in-vitro (1738) 1738
metabolism (1726) 1726
apoptosis (1715) 1715
time factors (1710) 1710
receptors (1708) 1708
plant sciences (1673) 1673
protein structure, secondary (1647) 1647
oncology (1633) 1633
gene (1631) 1631
signal transduction (1626) 1626
chemistry (1617) 1617
science (1609) 1609
genetic aspects (1606) 1606
dose-response relationship, drug (1600) 1600
rats, wistar (1598) 1598
insulin - blood (1587) 1587
biotechnology & applied microbiology (1581) 1581
cloning (1575) 1575
glucagon (1573) 1573
escherichia-coli (1555) 1555
brain (1544) 1544
polymer science (1538) 1538
gene-expression (1531) 1531
localization (1524) 1524
medicine, research & experimental (1521) 1521
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (138) 138
UofT at Mississauga - Stacks (30) 30
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Gerstein Science - Periodical Stacks (15) 15
Chemistry (A D Allen) - Stacks (12) 12
UTL at Downsview - May be requested (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Online Resources - Online (8) 8
UofT at Scarborough - Stacks (7) 7
Gerstein Science - Bindery (5) 5
Earth Sciences (Noranda) - Stacks (4) 4
Engineering & Comp. Sci. - Stacks (4) 4
Trinity College (John W Graham) - Stacks (4) 4
UofT at Scarborough - Withdrawn (2) 2
Chemistry (A D Allen) - Periodical Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Missing (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73758) 73758
Japanese (1043) 1043
Chinese (281) 281
German (279) 279
French (194) 194
Russian (144) 144
Spanish (78) 78
Polish (69) 69
Portuguese (63) 63
Korean (41) 41
Italian (33) 33
Czech (20) 20
Hungarian (14) 14
Dutch (12) 12
Croatian (6) 6
Turkish (6) 6
Norwegian (5) 5
Slovak (5) 5
Swedish (5) 5
Bulgarian (3) 3
Danish (3) 3
Serbian (3) 3
Finnish (2) 2
Greek (1) 1
Hebrew (1) 1
Latin (1) 1
Ndonga (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Soft matter, ISSN 1744-683X, 12/2014, Volume 11, Issue 2, pp. 422 - 422
Correction for 'Phase behaviour and complex coacervation of aqueous polypeptide solutions' by Dimitrios Priftis et al. , Soft Matter , 2012, 8 , 9396-9405. 
Polypeptides
Journal Article
Nature materials, ISSN 1476-4660, 2018, Volume 17, Issue 12, pp. 1164 - 1164
In the version of this Article originally published, one of the authors' names was incorrectly given as Jeffery Schaal; it should have been Jeffrey L. Schaal.... 
Polypeptides
Journal Article
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 04/2011, Volume 17, Issue 10, pp. 1002 - 1024
In neurological insults, such as cerebral ischemia and traumatic brain injury, complex molecular mechanisms involving inflammation and apoptosis are known to... 
G protein-coupled receptor | Neuroprotection | Stroke | Bioactive conformation | Traumatic brain injury | PACAP | Peptide drug design | VIP | CYCLASE-ACTIVATING POLYPEPTIDE | VASOACTIVE-INTESTINAL-PEPTIDE | BLOOD-BRAIN-BARRIER | CEREBELLAR GRANULE CELLS | HUMAN-SERUM-ALBUMIN | GLUCAGON-LIKE PEPTIDE-1 | PROTEIN-COUPLED RECEPTOR | N-TERMINAL ECTODOMAIN | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | DIABETIC DB/DB MICE | Neuroprotective Agents - therapeutic use | Receptors, G-Protein-Coupled - metabolism | Apoptosis - drug effects | Brain Injuries - drug therapy | Humans | Astrocytes - pathology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Drug Discovery - methods | Nerve Growth Factors - metabolism | Brain Ischemia - immunology | Brain Injuries - immunology | Neuroprotective Agents - adverse effects | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Cytokines - immunology | Astrocytes - drug effects | Cell Survival - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Brain Ischemia - drug therapy | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Brain Ischemia - pathology | Brain Injuries - pathology | Astrocytes - metabolism | Drugs | Cytokines | Astrocytes | Macromolecules | Inflammation | Drug development | Neuroprotective agents | Blood | Microglia | Pituitary adenylate cyclase-activating polypeptide | Chemical modification | Neurotransmitters | Side effects | Molecular modelling | Ischemia | Pharmacokinetics | Apoptosis
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, p. e0211433
Background PACAP and VIP are closely related neuropeptides with wide distribution and potent effect in the vasculature. We previously reported vasomotor... 
CYCLASE-ACTIVATING POLYPEPTIDE | HORMONE | VASOACTIVE-INTESTINAL-PEPTIDE | CORONARY | PHARMACOLOGICAL CHARACTERIZATION | MULTIDISCIPLINARY SCIENCES | PITUITARY | NEUROPEPTIDE | CEREBRAL-ARTERIES | VIP | EXPRESSION | Carotid Arteries - drug effects | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Insect Proteins - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Nitroprusside - pharmacology | Femoral Artery - drug effects | Mice, Knockout | Animals | Vasoactive Intestinal Peptide - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Carotid Arteries - physiology | Female | Femoral Artery - physiology | Mice | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Vasodilation - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - deficiency | Rats as laboratory animals | Research | Carotid artery | Vasoactive intestinal peptides | Health aspects | Femur | Femoral artery | Neuropeptides | Smooth muscle | Activation | Medical schools | Carotid arteries | Arteries | Vasodilation | Receptors | Rodents | Pituitary adenylate cyclase-activating polypeptide receptors | Physiology | Polypeptides | Migraine | Blood vessels | Gender differences | Anatomy & physiology | Gene expression | Polymerase chain reaction | Pituitary adenylate cyclase-activating polypeptide | Brain research | Isoforms | Females | Veins & arteries
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1241, pp. 29 - 35
Abstract Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are structurally endogenous peptides showing rich... 
Neurology | Schwannoma cells | PACAP | VIP | Apoptosis | SURVIVAL | CYCLASE-ACTIVATING POLYPEPTIDE | HUMAN BRAIN-TUMORS | VASOACTIVE-INTESTINAL-PEPTIDE | HUMAN PITUITARY-ADENOMAS | SPINAL-CORD | NEUROSCIENCES | MESSENGER-RNA | RAT-BRAIN | RECEPTORS | EXPRESSION | Vasoactive Intestinal Peptide - metabolism | Apoptosis - drug effects | Nerve Growth Factors - metabolism | RNA, Messenger - metabolism | Schwann Cells - cytology | Dose-Response Relationship, Drug | Nerve Growth Factors - pharmacology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Cell Survival - physiology | bcl-2-Associated X Protein - genetics | RNA, Messenger - drug effects | Schwann Cells - drug effects | Cell Survival - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | bcl-2-Associated X Protein - metabolism | Rats | Schwann Cells - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | bcl-2-Associated X Protein - drug effects | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Proto-Oncogene Proteins c-bcl-2 - drug effects | Cell Line, Tumor | Apoptosis - physiology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasoactive Intestinal Peptide - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Culture Media, Serum-Free - toxicity | Prevention | Adenylate cyclase | Polypeptides | Analysis | Vasoactive intestinal peptides | Gene expression | Index Medicus
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2008, Volume 34, Issue 6, pp. 833 - 843
Summary Exposure to chronic stress has been argued to produce maladaptive anxiety-like behavioral states, and many of the brain regions associated with... 
Endocrinology & Metabolism | Psychiatry | Fear | PAC 1 receptor | Corticotropin-releasing hormone | Extended amygdala | Plasticity | Vasoactive intestinal peptide | PAC | receptor | PAC receptor | RAT | PSYCHIATRY | IN-SITU HYBRIDIZATION | SYMPATHETIC NEURONS | NEUROSCIENCES | HYPOTHALAMIC PARAVENTRICULAR NUCLEUS | RECEPTOR-DEFICIENT MICE | NEURITE OUTGROWTH | ENDOCRINOLOGY & METABOLISM | POLYPEPTIDE PACAP | GENE-EXPRESSION | AMYGDALA | Brain-Derived Neurotrophic Factor - genetics | Septal Nuclei - drug effects | Neuronal Plasticity - drug effects | Male | Receptor, trkB - genetics | RNA, Messenger - metabolism | Septal Nuclei - metabolism | Neuronal Plasticity - genetics | Time Factors | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Stress, Psychological - metabolism | Behavior, Animal - drug effects | Brain-Derived Neurotrophic Factor - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Anxiety - metabolism | Stress, Psychological - chemically induced | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Adaptation, Psychological - drug effects | Rats | Behavior, Animal - physiology | Up-Regulation - genetics | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Rats, Sprague-Dawley | Up-Regulation - drug effects | Stress, Psychological - genetics | Anxiety - genetics | Animals | Models, Biological | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Anxiety - chemically induced | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Chronic Disease | Receptor, trkB - metabolism | Anxiety - etiology | Tyrosine | Adenylate cyclase | Messenger RNA | Polypeptides | ACTH | Hormones | Growth factors | corticotropin-releasing hormone | PAC1 receptor
Journal Article
Peptides (New York, N.Y. : 1980), ISSN 0196-9781, 2007, Volume 28, Issue 9, pp. 1631 - 1639
Journal Article
Journal of headache and pain, ISSN 1129-2369, 12/2018, Volume 19, Issue 1, pp. 1 - 9
textabstractPituitary adenylate cyclase activating polypeptide (PACAP) is an ubiquitous peptide involved, among others, in neurodevelopment, neuromodulation,... 
Neuroprotection | Ischemia | PACAP | Migraine | Neurology | Pain Medicine | Medicine & Public Health | Internal Medicine | MIDDLE CEREBRAL-ARTERY | CYCLASE-ACTIVATING POLYPEPTIDE | NEURONAL CELL-DEATH | BLOOD-BRAIN-BARRIER | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | CLINICAL NEUROLOGY | INDUCED CARDIOMYOCYTE APOPTOSIS | INDUCED RETINAL DEGENERATION | CENTRAL-NERVOUS-SYSTEM | BINDING-SITES | ADENYLATE-CYCLASE | Neuroprotective Agents - therapeutic use | Humans | Brain Ischemia - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Migraine Disorders - drug therapy | Neuroprotective Agents - metabolism | Migraine Disorders - metabolism | Animals | Neuroprotective Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Brain Ischemia - drug therapy | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Neurons - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Neurons - drug effects | Care and treatment | Cell receptors | Polypeptides | Development and progression | Genetic aspects | Health aspects | Pituitary adenylate cyclase-activating polypeptide | Headache | Pain perception | PAC1 protein | Therapeutic applications | Neurodevelopment | Neuromodulation
Journal Article
The Journal of Headache and Pain, ISSN 1129-2369, 12/2018, Volume 19, Issue 1, pp. 1 - 7
Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide implicated in a wide range of functions, such as nociception and in primary headaches.... 
Neurology | Pain Medicine | Receptors | Cluster headache | Medicine & Public Health | PACAP | Migraine | Internal Medicine | CGRP | CYCLASE-ACTIVATING POLYPEPTIDE | MIDDLE MENINGEAL ARTERY | NERVE-FIBERS | RECEPTOR MESSENGER-RNA | SPINAL-CORD | NEUROSCIENCES | TRIGEMINAL NUCLEUS CAUDALIS | CLINICAL NEUROLOGY | PEPTIDE PACAP | VASOACTIVE INTESTINAL POLYPEPTIDE | RAT-BRAIN | ADENYLATE-CYCLASE | Vasoactive Intestinal Peptide - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - analysis | Vasoactive Intestinal Peptide - analysis | Humans | Trigeminal Ganglion - chemistry | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Trigeminal Ganglion - metabolism | Headache Disorders, Primary - diagnosis | Headache Disorders, Primary - therapy | Ganglia, Parasympathetic - chemistry | Ganglia, Parasympathetic - metabolism | Neurons, Afferent - chemistry | Receptors, Vasoactive Intestinal Polypeptide, Type I - analysis | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Headache Disorders, Primary - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Neurons, Afferent - metabolism | Adenylate cyclase | Dosage and administration | Inhibitors | Drug therapy | Risk factors | Immunohistochemistry | Headache | PAC1 protein | Peptides | Brain stem | Smooth muscle | Choline O-acetyltransferase | Trigeminal nerve | Intestine | Vasoactive agents | Calcitonin | Sensory neurons | Acetyltransferase | Localization | Pain perception | Nitric-oxide synthase | Ganglia | Pituitary adenylate cyclase-activating polypeptide | Calcitonin gene-related peptide | Nitric oxide | Choline | Vasoactive intestinal peptide | Plasma levels | Trigeminal ganglion | Parasympathetic nervous system | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
Journal Article
Molecular metabolism (Germany), ISSN 2212-8778, 2018, Volume 18, pp. 3 - 14
Journal Article